According to new research, wearables like an Apple Watch or an Oura smart ring can detect the symptoms and predict flare-ups ...

Certolizumab pegol is approved by the FDA for reducing the signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who ...

The director of NIAID is appointed by the head of the NIH, who must be approved by the Senate. Directors have broad ...

IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a diagnostic solutions provider with a market capitalization of $6.4 million and showing a notable 16.6% year-to-date stock return, has received ...

Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from ...

Exercise: Regular exercise can help maintain a healthy body and weight, which lowers the risk of colon cancer. Aim for 150 ...

The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...

In India, hypothyroidism affects 1 in 10 adults, with 41.8% developing anaemia. Women are three times more likely to be ...

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...